Interstitial Lung Diseases
36
10
15
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 36 trials
100.0%
+13.4% vs benchmark
8%
3 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 11 completed trials
Clinical Trials (36)
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Home-based Pulmonary Rehabilitation in Interstitial Lung Disease
Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease
The Effects of Whole-Body Vibration Training on Clinical and Functional Outcomes in Individuals Diagnosed With Interstitial Lung Disease
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
Ultrasound and Respiratory Physiological Signals in Lung Diseases
Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis
Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases
A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis
Bronchoalveolar Lavage in Interstitial Lung Diseases to Characterization of Specific Inflammatory Cellular Infiltrate in Different Interstitial Lung Diseases
Interstitial Lung Diseases in Respiratory ICU
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
LetS Get fUnctional! FuNctional Status in pEople With intersTitial Lung Disease